Cocaine Use Disorder Market
Cocaine Use Disorder Market Infographics

Cocaine Use Disorder Market

Cocaine use disorder (CUD) is devastating, impacting individuals and society. CUD is the compulsive use of cocaine despite its medical, psychological, and behavioral consequences. It is a severe public health problem, affecting millions of people globally.


Cocaine Use Disorder Epidemiology Insights (2022)

  • The Cocaine use disorder 12-month diagnosed prevalent cases in 7MM were ~12.8 million in 2022
  • Cocaine use disorder 12-month diagnosed prevalent cases in the United States were ~62% in 2022
  • Cocaine use disorder 12-month diagnosed prevalent cases in EU4 and the UK were ~33% in 2022
  • Cocaine use disorder 12-month diagnosed prevalent cases in the Japan were ~5% in 2022


Cocaine Use Disorder Epidemiology Segmentation in the 7MM from 2019 to 2032

  • 12-month diagnosed prevalent cases
  • Gender-specific cases
  • Age-specific cases
  • Severity-specific cases


Cocaine Use Disorder Market Insight (2022)

Cocaine Use Disorder Market size in the 7MM was ~USD 48.3 million in 2022


Cocaine Use Disorder Emerging Drugs and Key Companies

  • STP7 (mavoglurant): STALICLA
  • EMB-001: Embera NeuroTherapeutics, and others